Results 201 to 210 of about 429,667 (356)

Chitosan Nanoparticles as Oral Drug Carriers. [PDF]

Int J Mol Sci, 2023
Guadarrama-Escobar OR, Serrano-Castañeda P, Anguiano-Almazán E, Vázquez-Durán A, Peña-Juárez MC, Vera-Graziano R, Morales-Florido MI, Rodriguez-Perez B, Rodriguez-Cruz IM, Miranda-Calderón JE, Escobar-Chávez JJ.   +10 more
europepmc   +1 more source

STUDY ON PREPARATION OF CHITOSAN NANOPARTICLE AS PROTEIN DELIVERY CARRIER FOR DRUG DELIVERY APPLICATION

, 2011
Tuyet Thi Anh Duong, Khương Quoc Võ, Phuong Hue Phan, Phong Nguyen   +3 more
openalex   +2 more sources

Genetic attenuation of ALDH1A1 increases metastatic potential and aggressiveness in colorectal cancer

Molecular Oncology, EarlyView.
Aldehyde dehydrogenase 1A1 (ALDH1A1) is a cancer stem cell marker in several malignancies. We established a novel epithelial cell line from rectal adenocarcinoma with unique overexpression of this enzyme. Genetic attenuation of ALDH1A1 led to increased invasive capacity and metastatic potential, the inhibition of proliferation activity, and ultimately ...
Martina Poturnajova, Zuzana Kozovska, Ondrej Pos, Kristina Pavlov, Sachin Gulati, Peter Makovicky, Kristina Jakic, Monika Burikova, Eva Sedlackova, Barbora Svitkova, Silvia Tyciakova, Vojtech Bystry, Nicolas Blavet, Boris Tichy, Matej Hrnciar, Jaroslav Budis, Miroslav Tomas, Peter Dubovan, Georgina Kolnikova, Veronika Repaska, Nikoleta Mojzesova, Eva Zomborska, Daniel Pindak, Michal Mego, Tomas Szemes, Miroslava Matuskova   +25 more
wiley   +1 more source

Special Issue "Novel Strategies in the Development of New Therapies, Drug Substances and Drug Carriers, 3rd Edition". [PDF]

Int J Mol Sci
Kutner A, Brown G, Kallay E.
europepmc   +1 more source

Lactoferrin treatment activates acetylcholinesterase, decreasing acetylcholine levels in non‐small cell lung cancer (NSCLC) cell culture supernatants, inhibiting cell survival

FEBS Open Bio, EarlyView.
Representation of the suggested mode of action of lactoferrin (Lf) in nonsmall cell lung cancer (NSCLC) A549 cells. Lf induces activation of caspase‐3 by activating p53 and AChE leading to decreased ACh concentrations. In turn, ACh signaling leads to activation of VEGF and AKT and blocking of caspase‐3.
Stuti Goel, Caroline Wozniak, Aya Sabri, Ben Haddad, Brooke Lopo, Alvaro Cobos, Sarah Sarofim, Jeffrey Guthrie, Deborah Heyl, Hedeel Guy Evans   +9 more
wiley   +1 more source

Botanical Drug Extracts Combined With Biomaterial Carriers for Osteoarthritis Cartilage Degeneration Treatment: A Review of 10 Years of Research

, 2022
Panyun Mu, Jie Feng, Yimei Hu, Feng Xiong, Xu Ma, Linling Tian   +5 more
openalex   +1 more source

Day/night variations of myeloid and lymphoid cell subsets in the murine inguinal lymph node

FEBS Open Bio, EarlyView.
The circadian system is involved in the temporal regulation of the immune system. Our study reveals that two innate immune populations, NKT cells and neutrophils, predominate at the beginning of the day in healthy mice, highlighting how the time of day influences immune responses.
Paula M. Wagner, César G. Prucca, Lucia Boffelli, Virginia A. Piqueras, Silvia G. Correa, Mariana Maccioni, Mario E. Guido   +6 more
wiley   +1 more source

Application of responsive nano-drug carriers in bone tumor chemotherapy. [PDF]

J Bone Oncol
Cai P, Fan M, Zheng P.
europepmc   +1 more source

Exosomes: potential diagnostic markers and drug carriers for adenomyosis. [PDF]

Front Pharmacol, 2023
Cheng WX, Wei SB, Zhou Y, Shao Y, Li MY.
europepmc   +1 more source

Direct Brain Targeted Nanostructured Lipid Carriers for Sustained Release of Schizophrenic Drug: Formulation, Characterization and Pharmacokinetic Studies [PDF]

, 2019
Praveen Sivadasu, Devagowda Vishakante Gowda, Nithin Kundachira Subramani, Bhavya Malgur Vishweshwaraiah, Sachhidananda Shivanna, Siddaramaiah Hatna   +5 more
openalex   +1 more source